Exertional dyspnoea in cardiorespiratory disorders : The clinical use of cardiopulmonary exercise testing by P. Laveneziana & P. Agostoni
Exertional dyspnoea in cardiorespiratory
disorders: the clinical use of
cardiopulmonary exercise testing
Pierantonio Laveneziana1,2 and Piergiuseppe Agostoni3,4
Affiliations: 1Sorbonne Universités, UPMC Université Paris 06, INSERM, UMRS 1158 Neurophysiologie
respiratoire expérimentale et clinique, Paris, France. 2Assistance Publique-Hôpitaux de Paris, Groupe
Hospitalier Pitié-Salpêtrière Charles Foix, Service des Explorations Fonctionnelles de la Respiration, de
l’Exercice et de la Dyspnée (Département “R3S”, Pôle PRAGUES), Paris, France. 3Centro Cardiologico
Monzino, IRCCS, Milan, Italy. 4Dept of Clinical Sciences and Community Health, Cardiovascular Section,
University of Milan, Milan, Italy.
Correspondence: Pierantonio Laveneziana, Service d’Explorations Fonctionnelles de la Respiration, de
l’Exercice et de la Dyspnée, Département “R3S” (Respiration, Réanimation, Réhabilitation, Sommeil), Pôle
PRAGUES, Hôpital Universitaire Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (AP-HP), 47-83
Boulevard de l’Hôpital, 75013, Paris, France. E-mail: pierantonio.laveneziana@aphp.fr
@ERSpublications
A series of articles on exertional dyspnoea in cardiorespiratory disorders begins in the European
Respiratory Review http://ow.ly/fLT0300uHgw
Is dyspnoea worth documenting and accurately assessing? The answer is undoubtedly yes, for at least the
following reasons. 1) Activity-related dyspnoea is usually the earliest and most troublesome complaint for
which patients with cardiopulmonary diseases seek medical attention. 2) This symptom progresses
relentlessly as the underlying disease advances, leading invariably to avoidance of activity with consequent
skeletal muscle deconditioning and an impoverished quality of life. 3) It is estimated that up to a quarter of
the general population and half of severely ill patients are affected by it. 4) Dyspnoea is also an important
predictor of quality of life, exercise tolerance and mortality in various conditions. In patients with chronic
obstructive pulmonary disease (COPD), it has been shown to be a better predictor of mortality than forced
expiratory volume in 1 s. In patients with heart disease referred for clinical exercise testing, it is a better
predictor of mortality than angina. 5) Dyspnoea is also associated with decreased functional status and
worse psychological health in older individuals living at home. 6) It is also a factor in the low adherence to
exercise training programmes in sedentary adults and in patients with COPD. 7) The effective management
of exertional dyspnoea remains a major challenge for caregivers and modern treatment strategies that are
based on attempts to reverse the underlying chronic condition are only partially successful [1–7].
The perception of dyspnoea involves the integration of afferent and efferent inputs at a cortical level and is
modulated by affective, emotional and behavioural components. The recent statements of the American
Thoracic Society (ATS) [8] and European Respiratory Society [1] have underlined the multidimensional
nature of dyspnoea which comprises three major dimensions: 1) the sensory-perceptual domain, 2) the
affective distress and 3) the symptom impact or burden.
Dyspnoea is a complex, multifaceted and highly personalised sensory experience, the source and
mechanisms of which are incompletely understood: there is no unique central or peripheral source of this
symptom. The definition given by the latest ATS statement (“a subjective experience of breathing discomfort
that consists of qualitatively distinct sensations that vary in intensity”) highlights the importance of the
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different qualities (descriptors) covered by the term dyspnoea, the cortical integration of multiple sources of
neural inputs about breathing, and the physiological, affective and behavioural consequences [8]. More
specifically, it is believed that dyspnoea arises when there is a conscious awareness of dissociation between
what the brain expects (through the “corollary discharge”, i.e. copy of the descending motor activity to
perceptual areas) and what it receives in terms of neural inputs from the respiratory system, respiratory
muscles, peripheral chemoreceptors and locomotor muscles [8]. Of course, not all conscious breathing
sensations are labelled as “dyspnoea” because the brain is able to “filter” all the respiratory sensations and let
only some of them reach the conscious level [1]. This sensory gating process hinders the brain from being
constantly overloaded by irrelevant sensory information. Human beings have the voluntary capacity to bring
“breathing” into awareness at any moment. However, breathing may come to conscious awareness
automatically if it needs to be attended to (gate-in). This “gating process” is instrumental in monitoring
essential biological and physiological functions, and adopting appropriate behaviour. It has been proposed
that respiratory sensations are the result of neural gating into the cerebral cortex of respiratory afferent input
eliciting a somatosensory cognitive awareness of breathing and an affective response [1].
It can be summarised in a very simplistic yet paedagogic way that dyspnoea may result from two
processes: 1) a discriminative one that identifies relevant afferent information on respiratory disruption/
abnormalities and brings them to consciousness (sensory components: intensity and quality); and 2) an
affective one that labels the now conscious sensation as unpleasant or threatening, i.e. dyspnoea.
Dyspnoea is not a single sensation, and our brain is able to distinguish among different afferent sources of
information and give each of them a distinct cognitive sensation, notably: 1) work/effort (“breathing
requires work or effort”); 2) tightness (“chest is constricted” or “chest feels tight”); and 3) air hunger
(“unsatisfied inspiration”, “starved for air”, “urge to breathe” or “like breath holding”). It is generally
accepted that these sensations do not share the same physiological mechanisms [1, 8]. Some of these
sensations, such as work/effort and air hunger, may exist and vary independently in the same subject or
experimental condition. Notwithstanding, whether there are multiple types of dyspnoea, whether they are
a subjective expression of different neurophysiological mechanisms, or the same neurophysiological
mechanisms may be expressed differently in relation to language, psychological, cultural and/or social
context is, at the moment, unclear and required additional research.
Dyspnoea can also be quantified (“intensity”). Exertional dyspnoea can be easily defined as “the perception
of respiratory discomfort that occurs for an activity level that does not normally lead to breathing
discomfort”. It follows that the intensity of dyspnoea can be determined by assessing the activity level
required to produce dyspnoea (i.e. dyspnoea at rest is more severe than dyspnoea when climbing stairs) [1].
Dyspnoea can therefore be evaluated during a physical task, such as cardiopulmonary exercise testing
(CPET) [1, 8]. For this purpose, the 10-point Borg scale can be used to rate a specific respiratory sensation
(e.g. inspiratory difficulty, breathing effort, expiratory difficulty or air hunger) or a more general one
(e.g. breathing difficulty or breathlessness). The magnitude of respiratory sensation should be anchored at
both extremes of the scale such that a rating of “0” represents no breathing discomfort and “10” represents
the maximal breathlessness that the subject had ever experienced or could imagine experiencing. Though
somewhat less popular, the visual analogue scale (VAS) is another dyspnoea-measuring instrument with
proven construct validity used during CPET. Both the VAS and Borg scale have been shown to provide
similar scores during CPET, and to be reliable and reproducible over time in healthy subjects, and in patients
with chronic respiratory diseases undergoing CPET [9]. The advantage of using the Borg or VAS scales in
individual patients is the possibility of reliably comparing “intensity of exertional dyspnoea” at the same level
of exercise activity (standardised work-rate or oxygen consumption or ventilation during CPET) between
subjects, and before and after a pharmacological and/or nonpharmacological treatment [9]. Studies in
cardiopulmonary diseases have shown that during CPET, there is a close correlation between the magnitude
(and duration) of respiratory effort (measured by tidal oesophageal pressure relative to maximum) and the
intensity of dyspnoea (measured by the Borg scale), and that pharmacological manipulations able to reduce
the magnitude (and duration) of respiratory effort are clearly and consistently associated with reduced
dyspnoea intensity [1, 9].
Quality and quantity of dyspnoea can also be measured together during CPET. Few studies have shown that
moderate-to-severe COPD and even mild stable asthmatics are able to “perceive” dynamic changes in their
mechanics of breathing during exercise: once a critical inspiratory reserve volume (IRV) is attained (0.3–0.5 L
from total lung capacity), tidal volume expansion is critically constrained, dyspnoea intensity rises abruptly
and there is a transition in the dominant qualitative descriptor choice from work/effort to difficult/unsatisfied
inspiration [1]. The clinical relevance of these findings is that by asking the quality of dyspnoea at the end of
an exercise bout one can ascertain whether a critical IRV (difficult/unsatisfied inspiration) or not (work/
effort) has been reached, i.e. the likelihood of developing exercise-related critical volume constraints [1].
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Things are, however, somehow different in chronic heart failure. Indeed, heart failure patients may report
dyspnoea alone or in variable combination with leg discomfort as the exercise-limiting symptoms. In heart
failure, no haemodynamic and respiratory variables, either at rest or during exercise, seem to be able to
discriminate between heart failure patients who complain of dyspnoea as the predominant exercise
limiting symptom from those who report leg discomfort. Clearly the issue is still unsolved and more
studies are needed [1].
CPET is therefore well suited for understanding mechanisms underlying dyspnoea during exercise
(exertional dyspnoea) both in research and clinical settings. CPET may also help clinicians identify
additional mechanisms underpinning the greater dyspnoea intensity that could be independent of or not
directly related to the main/obvious pathophysiological determinant of the disease under consideration.
We hope we have convinced readers of the importance of assessing dyspnoea on exertion. A clinical series
of articles starting in this issue of the European Respiratory Review [10, 11] will therefore focus on the
clinical use of CPET to explore and unmask the mechanisms underlying dyspnoea during exercise in an
abroad spectrum of cardiorespiratory disorders, covering topics including exertional dyspnoea in COPD,
chronic heart failure, asthma, obesity, pulmonary arterial hypertension and interstitial lung diseases.
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